These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27703672)

  • 1. Ending the HIV/AIDS epidemic in low- and middle-income countries by 2030: is it possible?
    Harries AD; Suthar AB; Takarinda KC; Tweya H; Kyaw NT; Tayler-Smith K; Zachariah R
    F1000Res; 2016; 5():2328. PubMed ID: 27703672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and Australia.
    Marukutira T; Stoové M; Lockman S; Mills LA; Gaolathe T; Lebelonyane R; Jarvis JN; Kelly SL; Wilson DP; Luchters S; Crowe SM; Hellard M
    J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29508945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource needs and gap analysis in achieving universal access to HIV/AIDS services: a data envelopment analysis of 45 countries.
    Zeng W; Shepard DS; Avila-Figueroa C; Ahn H
    Health Policy Plan; 2016 Jun; 31(5):624-33. PubMed ID: 26552409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress towards 2020 global HIV impact and treatment targets.
    Mahy MI; Sabin KM; Feizzadeh A; Wanyeki I
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25779. PubMed ID: 34546655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
    Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
    PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.
    Donoghoe MC; Verster A; Pervilhac C; Williams P
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S5-14. PubMed ID: 18243681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Antiretroviral Treatment for HIV.
    Badowski ME; Pérez SE; Biagi M; Littler JA
    Infect Dis Ther; 2016 Sep; 5(3):329-52. PubMed ID: 27539455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International response to the HIV/AIDS epidemic: planning for success.
    Piot P; Coll Seck AM
    Bull World Health Organ; 2001; 79(12):1106-12. PubMed ID: 11799442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving the 95 95 95 targets for all: A pathway to ending AIDS.
    Frescura L; Godfrey-Faussett P; Feizzadeh A A; El-Sadr W; Syarif O; Ghys PD;
    PLoS One; 2022; 17(8):e0272405. PubMed ID: 35925943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UNAIDS calls for progress against TB/HIV epidemic.
    AIDS Alert; 1998 Jun; 13(6):suppl 3. PubMed ID: 11365465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.
    Stover J; Bollinger L; Izazola JA; Loures L; DeLay P; Ghys PD;
    PLoS One; 2016; 11(5):e0154893. PubMed ID: 27159260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What will it take to end AIDS in Asia and the Pacific region by 2030?
    Murphy E; Shwe YY; Bhatia R; Bakkali T; Vannakit R
    Sex Health; 2021 Mar; 18(1):41-49. PubMed ID: 33653504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards achieving the fast-track targets and ending the epidemic of HIV/AIDS in Ethiopia: Successes and challenges.
    Assefa Y; Gilks CF; Dean J; Tekle B; Lera M; Balcha TT; Getaneh Y; Van Damme W; Hill PS
    Int J Infect Dis; 2019 Jan; 78():57-64. PubMed ID: 30391417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2.
    Gottlieb GS; Raugi DN; Smith RA
    Lancet HIV; 2018 Jul; 5(7):e390-e399. PubMed ID: 30052509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ending infectious diseases in the era of the Sustainable Development Goals.
    Raviglione M; Maher D
    Porto Biomed J; 2017; 2(5):140-142. PubMed ID: 32258607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Setting the scene, setting the targets. The Joint United Nations Programme on HIV/AIDS prevention targets of 2016 and estimating global pre-exposure prophylaxis targets.
    Coleman R
    Sex Health; 2018 Nov; 15(6):485-488. PubMed ID: 30496717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [1986-2006: 20 years of failed international policy to control AIDS in Africa].
    Kerouedan D
    Med Trop (Mars); 2007 Oct; 67(5):515-28. PubMed ID: 18225738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critique of the financial requirements to fight HIV/AIDS.
    Gordon JG
    Lancet; 2008 Jul; 372(9635):333-6. PubMed ID: 18657712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].
    Agonnoude MT; Mesenge C
    Sante; 2010; 20(2):116-24. PubMed ID: 20685643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.